Helical β-peptide inhibitors of the p53-hDM2 interaction

Journal of the American Chemical Society

Volumn 126, Issue 31, 2004, Pages 9468-9469

  Kritzer, Joshua A ^a   Lear, James D ^b   Hodsdon, Michael E ^c   Schepartz, Alanna ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA PEPTIDE; ONCOPROTEIN; PEPTIDE; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ALPHA HELIX; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CANCER; CIRCULAR DICHROISM; CRYSTAL STRUCTURE; FLUORESCENCE POLARIZATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ULTRACENTRIFUGATION;

CIRCULAR DICHROISM; FLUORESCENCE POLARIZATION; HUMANS; MODELS, MOLECULAR; NUCLEAR PROTEINS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3543098742     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja031625a     Document Type: Article

References (28)

1. (a) Schreiber, J. V.; Frackenpohl, J.; Moser, F.; Fleischmann, T.; Kohler, H. P. E.; Seebach, D. ChemBioChem 2002, 3, 424.
2. (b) Seebach, D.; Overhand, M.; Kuhnle, F. N. M.; Martinoni, B.; Oberer, L.; Hommel, U.; Widmer, H. Helv. Chim. Acta 1996, 79, 913.
3. (c) Seebach, D.; Abele, S.; Schreiber, J. V.; Martinoni, B.; Nussbaum, A. K.; Schild, H.; Schulz, H.; Hennecke, H.; Woessner, R.; Bitsch, F. Chimia 1998, 52, 734.
4. (d) Gademann, K.; Kimmerlin, T.; Hoyer, D.; Seebach, D. J. Med. Chem. 2001, 44, 2460.
5. (e) Gademann, K.; Ernst, M.; Hoyer, D.; Seebach, D. Angew. Chem., Int. Ed. 1999, 38, 1223.
6. (f) Gelman, M. A.; Richter, S.; Cao, H.; Umezawa, N.; Gellman, S. H.; Rana, T. M. Org. Lett. 2003, 5, 3563.
7. (g) Arvidsson, P. I.; Frackenpohl, J.; Seebach, D. Helv. Chim. Acta 2003, 86, 1522.
8. (h) Park, J. S.; Lee, H. S.; Lai, J. R.; Kim, B. M.; Gellman, S. H. J. Am. Chem. Soc. 2003, 125, 8539.
9. (i) Raguse, T. L.; Lai, J. R.; Gellman, S. H. J. Am. Chem. Soc. 2003, 725, 5592.
10. (j) Cheng, R. P.; DeGrado, W. F. J. Am. Chem. Soc. 2002, 724, 11564.
11. (k) Reinelt, S.; Marti, M.; Dedier, S.; Reitinger, T.; Folkers, G.; de Castro, J. A. L.; Rognan, D. J. Biol. Chem. 2001, 276, 24525.
12. (a) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev. 2001, 101, 3219.
13. (b) DeGrado, W. F.; Schneider, J. P.; Hamuro, Y. J. Pept. Res. 1999, 54, 206.
14. (a) Kussie, P. H.; Gorina, S.; Marechal, V.; Elenbaas, B.; Moreau, J.; Levine, A. J.; Pavletich, N. P. Science 1996, 274, 948.
15. (b) Chene, P. Nat. Rev. Cancer 2003, 3, 102.
16. (c) Schon, O.; Friedler, A.; Bycroft, M.; Freund, S. M. V.; Fersht, A. R. J. Mol. Biol. 2002, 323, 491.
17. (d) Bottger, A.; Bottger, V.; Garcia-Echeverria, C.; Chene, P.; Hochkeppel, H. K.; Sampson, W.; Ang, K.; Howard, S. F.; Picksley, S. M.; Lane, D. P. J. Mol. Biol. 1997, 269, 744.
18. (e) Massova, I.; Kollman, P. A. J. Am. Chem. Soc. 1999, 121, 8133.
19. (f) Garcia-Echeverria, C.; Chene, P.; Blommers, M. J. J.; Furet, P. J. Med. Chem. 2000, 43, 3205.
20. (g) Chene, P.; Fuchs, J.; Carena, I.; Furet, P.; Echeverria, C. G. FEBS Lett. 2002, 529, 293.
21. (h) Vassilev, L. T.; Vu, B. T.; Graves, B.; Carvajal, D.; Podlaski, F.; Filipovic, Z.; Kong, N.; Kammlott, U.; Lukacs, C.; Klein, C.; Fotouhi, N.; Liu, E. A. Science 2004, 303, 844.
22. Hart, S. A.; Bahadoor, A. B. F.; Matthews, E. E.; Qiu, X. Y. J.; Schepartz, A. J. Am. Chem. Soc. 2003, 125, 4022.
23. β53-2 was soluble only to ∼75 μM.
24. See Supporting Information for details.
25. (a) Knight, S. M. G.; Umezawa, N.; Lee, H. S.; Gellman, S. H.; Kay, B. K. Anal. Biochem. 2002, 300, 230.
26. (b) Lai, Z. H.; Auger, K. R.; Manubay, C. M.; Copeland, R. A. Arch. Biochem. Biophys. 2000, 381, 278.
27. Rutledge, S. E.; Volkman, H. M.; Schepartz, A. J. Am. Chem. Soc. 2003, 125, 14336.
28. Kritzer, J. A.; Schepartz, A. Unpublished results.